Bucking Convention, AavantiBio Co-Founder Marries Clinical Physical Therapy with Gene Therapy Research
There is no single road to leadership in biotech, as In Vivo Rising leader Manuela Corti demonstrates. The physical therapist shares her passion for treating neuromuscular disorders, the urgency of commercializing gene therapy treatment for these diseases, and the value of infusing the work environment with some fun.
More from Rising Leaders
More from Leadership
With British Science Week upon us, how are UK life science firms faring, what’s the outlook for the future, and how can the environment be improved to better foster innovation – and make it pay?
Rentschler Biopharma CEO Benedikt von Braunmühl tells In Vivo about the CDMO's strategic decision to exit the cell and gene therapy manufacturing space.
Twenty executives in the biopharma industry outline their expectations for key trends and developments this year. A selection of commentary from a broad industry survey by Scrip.